The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

Christina Fitzmaurice, Christine A. Allen, Ryan M Barber et al. · JAMA Oncology · 2016 · 6.3K citations · Full text

Medicine, Oncology, Population Health Sciences +17

Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity

Andrea Casazza, Damya Laoui, Mathias Wenes et al. · Cancer Cell · 2013 · 617 citations · Full text

Medicine, Cancer Biology, Oncology +17

Projections of primary liver cancer to 2030 in 30 countries worldwide

Patricia C. Valery, Mathieu Laversanne, Paul J. Clark et al. · Hepatology · 2017 · 339 citations · Full text

Medicine, Oncology, Cancer Control +16

EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells

Young Do Jung, Min-Gyun Kim, B A Shin et al. · British Journal of Cancer · 2001 · 331 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor angiogenesis: review of current applications in tumor prognostication.

Noel Weidner · PubMed · 1993 · 250 citations

Medicine, Cancer Biology, Oncology +16